Cash & Equivalents
Stryker Cash & Equivalents increased by 37.1% to $3.26B in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 15.4%, from $3.85B to $3.26B. Over 4 years (FY 2020 to FY 2024), Cash & Equivalents shows an upward trend with a 5.5% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase signals improved liquidity and financial flexibility, while a decrease may indicate heavy capital expenditure, debt repayment, or aggressive share buybacks.
Detailed definition
Represents the most liquid assets on the balance sheet, including physical currency and short-term investments with matu...
Peer comparison
Large-cap technology peers often maintain high cash balances to fund rapid innovation and offset the cyclical nature of consumer electronics.
cash_and_equivalentsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.24B | $2.56B | $2.94B | $1.46B | $1.04B | $1.42B | $1.84B | $1.67B | $1.40B | $1.86B | $2.97B | $2.33B | $1.87B | $3.85B | $3.65B | $2.32B | $2.38B | $3.26B |
| QoQ Change | — | +14.4% | +14.9% | -50.5% | -28.4% | +36.0% | +29.9% | -9.4% | -16.2% | +32.8% | +59.7% | -21.6% | -19.6% | +105.4% | -5.1% | -36.5% | +2.4% | +37.1% |
| YoY Change | — | — | — | — | -53.4% | -44.6% | -37.4% | +14.6% | +34.2% | +31.0% | +61.1% | +39.4% | +33.8% | +107.0% | +22.9% | -0.4% | +26.7% | -15.4% |
Cash & Equivalents at Other Companies
Frequently Asked Questions
- What is Stryker's cash & equivalents?
- Stryker (SYK) reported cash & equivalents of $3.26B in Q3 2025.
- How has Stryker's cash & equivalents changed year-over-year?
- Stryker's cash & equivalents decreased by 15.4% year-over-year, from $3.85B to $3.26B.
- What is the long-term trend for Stryker's cash & equivalents?
- Over 4 years (2020 to 2024), Stryker's cash & equivalents has grown at a 5.5% compound annual growth rate (CAGR), from $2.94B to $3.65B.
- What does cash & equivalents mean?
- Money in the bank and very short-term investments that can be turned into cash almost instantly.